Article Information
History
- December 19, 2019.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Michael Marks1,2,*,
- Sarah Gwyn3,
- Hilary Toloka4,
- Christian Kositz1,
- James Asugeni4,
- Rowena Asugeni4,
- Jason Diau4,
- John M Kaldor5,
- Lucia Romani5,
- Michelle Redman-MacLaren6,
- David MacLaren6,
- Anthony W Solomon1,2,
- David CW Mabey1,2,
- Andrew C Steer7,8,9 and
- Diana Martin3
- 1Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, United Kingdom
- 2Hospital for Tropical Diseases, University College London Hospitals NHS Trust, London, WC1E 6JB, United Kingdom
- 3Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, United States of America
- 4Atoifi Adventist Hospital, Atoifi, Malaita Province, Solomon Islands
- 5Kirby Institute, University of New South Wales, Sydney, Australia
- 6College of Medicine and Dentistry, James Cook University, Cairns, Queensland, Australia
- 7Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia
- 8Department of General Medicine, Royal Children’s Hospital, Melbourne, Victoria, Australia
- 9Tropical Diseases Research Group, Murdoch Children’s Research Institute, Melbourne, Victoria, Australia
- ↵*Author for Correspondence:
Michael Marks, Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, United Kingdom, michael.marks{at}lshtm.ac.uk
Posted December 19, 2019.
Impact of community treatment with ivermectin for the control of scabies on the prevalence of antibodies to Strongyloides stercoralis in children
